Drug Repurposing of Loratadine as a DNMT1 Inhibitor: Comparative Evaluation with Cisplatin in Patient-Derived Oral Squamous Cell Carcinoma Cells. Precis. Med. Com. [Internet]. 2024 Dec. 30 [cited 2026 Apr. 3];4(2):125-37. Available from: https://rootspress.org/journals/PMC/article/view/1083